-
公开(公告)号:EP4421937A1
公开(公告)日:2024-08-28
申请号:EP23197391.8
申请日:2023-09-14
发明人: KIM, Myunghoon , KIM, Yunhee , PARK, Injun , KIM, Aeran , OH, Seungryong , SHIN, Jeongmin
IPC分类号: H01M10/0568 , H01M10/0567 , H01M10/0525 , H01M4/525
CPC分类号: H01M10/0567 , H01M4/525 , H01M10/0525 , H01M10/0568 , H01M2300/002520130101
摘要: A rechargeable lithium battery according to an embodiment of the present invention comprises a positive electrode comprising a positive electrode active material; a negative electrode comprising a negative electrode active material; and an electrolyte solution comprising a non-aqueous organic solvent, a lithium salt, and an additive. The positive electrode active material comprises a composite oxide having a nickel content of greater than about 8o mol% based on a total amount of metals except lithium. In addition, the lithium salt comprises a compound represented by Chemical Formula 1; the additive comprises a compound represented by Chemical Formula 2, and the compound represented by Chemical Formula 1 is comprised in about to wt% to about 8o wt% based on a total amount of the lithium salt.
Details of Chemical Formulas 1 and 2 are as described in the specification.-
2.
公开(公告)号:EP4399364A1
公开(公告)日:2024-07-17
申请号:EP22799968.7
申请日:2022-09-07
发明人: BONDS, Chris , DU TOIT, Stephan , BULSON, Ben , TELLIER, Guillaume , WINDEBANK, Mark , SKUSE, David
CPC分类号: D21H11/18 , D21C9/007 , D21C9/002 , D21B1/34 , B01F33/821 , B01F27/411 , B01F27/27 , B01F27/40 , B01F27/90
-
公开(公告)号:EP4309738A3
公开(公告)日:2024-07-17
申请号:EP23199696.8
申请日:2016-10-05
IPC分类号: A61K31/5377 , C07D405/14 , C07D211/86 , C07D405/12 , A61K31/4412 , A61K31/4436 , A61K31/4468 , A61K31/4545 , A61K31/496 , A61K31/501 , A61P35/00
CPC分类号: A61K31/501 , A61K31/4412 , A61K31/4436 , A61K31/4468 , A61K31/4545 , A61K31/496 , A61K31/5377 , A61P35/00
摘要: The disclosure provides a method of treating a medulloblastoma in a subject in need thereof comprising administering to the subject a therapeutically-effective amount of an enhancer of a zeste homolog 2 (EZH2) inhibitor. In a preferred embodiment of this method, the subject is pediatric and the EZH2 inhibitor is Tazemetostat.
-
4.
公开(公告)号:EP4286491A3
公开(公告)日:2024-03-06
申请号:EP23201879.6
申请日:2021-04-22
发明人: UNO, Takuya
IPC分类号: C07D307/77 , C07D333/76 , C09K11/06 , C07D333/50 , C07D405/12 , C07D409/12 , C07D493/10 , C07D495/10 , C07F7/08
摘要: A polycyclic compound represented by Formula 1 and an organic electroluminescence device that comprises a first electrode, a hole transport region disposed on the first electrode, an emission layer disposed on the hole transport region, an electron transport region disposed on the emission layer, and a second electrode disposed on the electron transport region, wherein the hole transport region comprises a polycyclic compound represented by Formula 1:
-
5.
公开(公告)号:EP4311848A1
公开(公告)日:2024-01-31
申请号:EP23186328.3
申请日:2023-07-19
发明人: Ko, Soobyung , Lee, Eunyoung , Kang, Iljoon , Shin, Sujin , Lee, Youngki , Jeon, Mina , Chu, Changwoong
摘要: An organic light-emitting device comprises a first electrode, a second electrode facing the first electrode, and an interlayer between the first electrode and the second electrode and comprising an organometallic compound represented by Formula 1. In addition, an electronic apparatus comprising the light-emitting device, a composition comprising the organometallic compound represented by Formula 1, and an organometallic compound represented by Formula 1 are also provided.
-
公开(公告)号:EP4288422A1
公开(公告)日:2023-12-13
申请号:EP22706022.5
申请日:2022-02-08
申请人: Floratek Pharma SA
IPC分类号: C07D311/30 , C07D405/12 , C07D413/12 , C07D493/14 , A61K31/352 , A61K31/405 , A61K31/4433 , A61K45/06 , A61P35/00 , A61P35/02 , A61K31/4025
-
公开(公告)号:EP4284517A1
公开(公告)日:2023-12-06
申请号:EP22705023.4
申请日:2022-01-26
申请人: Floratek Pharma SA
IPC分类号: A61P35/00 , C07F9/655 , C07F9/6561
-
公开(公告)号:EP4252851A3
公开(公告)日:2023-11-22
申请号:EP23174369.1
申请日:2015-06-17
发明人: KEILHACK, Heike , OTTESEN, Lone , REYDERMAN, Larisa , JOHNSTON, L. Danielle , KNUTSON, Sarah K.
IPC分类号: A61K31/4412 , A61K31/5377 , A61K31/444 , A61P35/00 , A61P35/02
摘要: The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and their use for the treatment of cancer.
-
公开(公告)号:EP3940813B1
公开(公告)日:2023-10-18
申请号:EP21185573.9
申请日:2021-07-14
发明人: SHIN, Changsu , CHU, Heeyoung , KIM, Youngugk , KIM, Jaemyung , YOUM, Chul , WON, Jongmin , LEE, Dae-Hyeok , LEE, Jungho
-
公开(公告)号:EP3352003B1
公开(公告)日:2023-10-18
申请号:EP18151482.9
申请日:2018-01-12
发明人: JUNG, Jin Soo , KIM, Young Gu , LEE, Taek Joon , JANG, Hye Lim , JEON, Baek Kyun
IPC分类号: G02F1/1335 , G02F1/13357 , C08G59/24 , C08G59/38
-
-
-
-
-
-
-
-
-